A leukemia diagnosis is one of the most frightening things a person can hear. Then, often within days, comes a second wave of fear: the cost of treatment in the US, UK, or Australia, or the realisation that a matched donor or a specialist slot could be months away. You are not being unreasonable to look elsewhere.
The good news, offered with honesty rather than hype: leukemia treatment cost in India is typically 70-90% lower than in Western countries, and the hospitals that treat these patients hold the same international accreditations that matter to you and your family.
How Much Does Leukemia Treatment Cost in India?
Leukemia treatment cost in India ranges from approximately $5,000 to $8,000 for a full chemotherapy induction course to $25,000-$50,000 for an allogeneic bone marrow transplant (BMT). By comparison, the same BMT in the United States routinely costs $300,000 to $600,000, and in the UK even privately insured patients can face bills above £200,000.
These figures typically cover hospital stay, haematologist fees, nursing care, diagnostic tests, and standard protocol medications. Targeted therapies, newer oral agents, and CAR-T cell treatment are priced separately and covered further below.
What Shapes the Final Cost?
Several factors will move your quote up or down:
- Type of leukemia: ALL (Acute Lymphoblastic), AML (Acute Myeloid), CML (Chronic Myeloid), and CLL (Chronic Lymphocytic) each follow different treatment pathways with different durations and drug costs.
- Phase of treatment: Induction, consolidation, and maintenance chemotherapy carry different inpatient requirements and drug volumes.
- BMT donor type: Autologous transplants using the patient’s own stored stem cells cost less than allogeneic transplants requiring a matched sibling or unrelated donor.
- Hospital tier and city: Accredited hospitals in Mumbai, Delhi, and Chennai command slightly higher fees; equally accredited centres in Hyderabad, Ahmedabad, or Pune are often 10-20% more affordable.
- Length of stay: A standard chemotherapy cycle requires 10-21 days inpatient; a full BMT protocol calls for 6-8 weeks in hospital followed by 60-90 days of monitored recovery nearby.
Cost Comparison: India vs US, UK, Australia, UAE
| Treatment | India (approx.) | United States | United Kingdom | Australia | UAE |
|---|---|---|---|---|---|
| Chemotherapy induction (full course) | $5,000 – $8,000 | $80,000 – $150,000 | £40,000 – £80,000 | AUD 60,000 – 120,000 | $40,000 – $80,000 |
| Autologous BMT | $18,000 – $28,000 | $250,000 – $450,000 | £150,000 – £250,000 | AUD 200,000 – 350,000 | $80,000 – $150,000 |
| Allogeneic BMT (matched donor) | $25,000 – $50,000 | $300,000 – $600,000 | £200,000 – £350,000 | AUD 280,000 – 500,000 | $100,000 – $180,000 |
| Targeted therapy / TKI (6 months) | $3,000 – $8,000 | $50,000 – $120,000 | £30,000 – £70,000 | AUD 40,000 – 100,000 | $20,000 – $50,000 |
| CAR-T cell therapy | $60,000 – $90,000 | $450,000 – $600,000 | £350,000 – £500,000 | AUD 500,000+ | $150,000 – $250,000 |
All figures are indicative 2026 ranges and exclude travel, accommodation, and companion expenses. Exact quotes depend on the treating hospital and individual clinical assessment.
Chemotherapy for Leukemia in India
Chemotherapy remains the foundation of leukemia treatment and the first-line approach for most newly diagnosed patients. Induction chemotherapy for ALL or AML in India typically spans 28-35 days of inpatient care. The agents used, including anthracyclines, cytarabine, vincristine, and asparaginase, are the same molecules used in globally recognised protocols such as BFM, CALGB, and MRC regimens.
This is worth stating plainly: you are not receiving inferior drugs because you are in India. India is one of the world’s largest manufacturers of generic pharmaceuticals, which is precisely why the same treatment costs a fraction of what it does in the US or Europe.
“Our medical oncology teams follow the same evidence-based protocols as leading cancer centres in the US and Europe. Patients access identical drug regimens, often at dramatically lower cost, without any compromise to the standard of care.” This reflects the consistent position of oncologists at JCI-accredited hospitals across India.
Explore our hospitals for the full list of accredited cancer centres IndoMedTour works with, along with their specialisations.
Bone Marrow Transplant (BMT) Cost in India
A bone marrow transplant, more precisely called a haematopoietic stem cell transplant (HSCT), is the treatment most families researching leukemia care worry about most, and it is also where India’s cost advantage is most striking.
Autologous vs Allogeneic: Which Is Right for Your Case?
- Autologous BMT: Uses the patient’s own stem cells, collected, frozen, and reinfused after high-dose conditioning chemotherapy. Lower risk of graft-versus-host disease; typically used for CML in remission or selected AML cases. Cost in India: approximately $18,000-$28,000.
- Allogeneic BMT: Uses stem cells from a matched sibling, haplo-identical family member, or unrelated donor. This is the definitive curative option for many ALL and AML patients. Cost in India: approximately $25,000-$50,000 for the full 100-day protocol.
India has a growing domestic donor registry and routinely accepts internationally identified unrelated donors. Waiting times for bed allocation at top BMT centres are generally 4-8 weeks from confirmed eligibility, considerably shorter than in many Western systems.
Hospitals operating BMT programmes at the level IndoMedTour recommends hold both NABH accreditation, India’s national hospital quality standard, and in most cases JCI (Joint Commission International) accreditation, the global benchmark. These are not ceremonial certificates; they require rigorous, recurring audits of infection control, transfusion medicine, graft protocols, and survival outcomes reporting.
For more on the transplant journey, see our organ transplant page or browse treatments and costs for a broader overview.
CAR-T Cell Therapy for Leukemia: India’s Newest Advantage
CAR-T (Chimeric Antigen Receptor T-cell) therapy represents a genuine revolution in blood cancer treatment, particularly for relapsed or refractory ALL and certain AML subtypes. In the US, a single course is priced at $450,000-$600,000, putting it out of reach for almost every uninsured or underinsured patient worldwide.
India now has select JCI-accredited centres offering approved CAR-T products at $60,000-$90,000, a saving of $350,000 or more compared to the US. Both internationally licensed products such as Kymriah (tisagenlecleucel) and domestically developed CAR-T therapies approved by India’s Central Drugs Standard Control Organisation (CDSCO) are available at these centres.
Waiting times from eligibility confirmation to infusion are typically 4-8 weeks at India’s leading CAR-T centres, significantly shorter than the 3-6 month waits many US and UK patients experience.
For a detailed look at blood cancer care pathways available through IndoMedTour, visit our cancer oncology page.
Quality and Safety: The Questions You Should Ask
It is entirely sensible to ask whether saving money involves any compromise in safety. For the top-tier hospitals IndoMedTour partners with, the honest answer is no. Here is a practical checklist of quality markers to verify before committing to any hospital:
- JCI or NABH accreditation (non-negotiable for our referrals)
- Dedicated BMT unit with HEPA-filtered laminar flow rooms and positive-pressure isolation
- 24-hour intensivist coverage in the BMT unit
- Certified haematologists with subspecialty BMT training, ideally with international fellowship experience
- Multidisciplinary tumour board review before treatment begins
- Documented outcomes data, specifically 100-day and 1-year post-transplant survival rates
- On-site blood bank with CMV-negative and irradiated products available
- Infectious disease specialist embedded in the BMT team
We encourage families to also read success stories from patients who completed treatment in India to understand what the real-world experience looks like across different leukemia types and treatment phases.
Practical Budgeting: What to Add Beyond Hospital Costs
Medical fees are only part of the picture. For a realistic total travel-treatment budget, factor in:
- Flights: Approximately $600-$2,500 per person return, depending on origin country
- Accommodation: Good guesthouses near major hospitals run $30-$80 per night; serviced apartments suitable for a longer BMT stay range from $800-$1,500 per month
- Companion expenses: Food, local transport, and day-to-day costs typically run $20-$40 per day
- Medical visa (category MV): India’s medical visa is straightforward and typically issued within 5-7 working days; fees range from free to approximately $80 depending on nationality
For a standard chemotherapy induction with a 30-35 day stay including flights and accommodation, a realistic all-in budget is $8,000-$15,000. For a full allogeneic BMT protocol requiring a three-month stay, total costs including travel and living expenses remain well under $70,000 for most origin countries, compared to $400,000-$700,000 or more for the same treatment in the US.
Understanding the full journey from inquiry to recovery is important. See how it works for the step-by-step process IndoMedTour guides patients through.
How IndoMedTour Helps
Navigating a leukemia diagnosis is hard enough without trying to compare transplant units across a country you have never visited. When you book a free counselling call with IndoMedTour, our team reviews your diagnosis and medical records, matches you with the accredited hospital best suited to your specific leukemia subtype and planned treatment pathway, and obtains written cost estimates in advance so there are no financial surprises after you land. We coordinate your medical visa, airport transfers, and local logistics, and a dedicated patient coordinator stays beside you, your companion, and your clinical team from the first consultation through discharge and into your recovery period. You bring the worry. We bring the plan.